Truist Securities Maintains Hold on NextGen Healthcare, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh maintains a Hold rating on NextGen Healthcare (NASDAQ:NXGN) and lowers the price target from $22 to $18.
May 22, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities maintains a Hold rating on NextGen Healthcare and lowers the price target from $22 to $18.
The lowered price target from $22 to $18 by Truist Securities analyst Jailendra Singh indicates a less optimistic outlook for NextGen Healthcare's stock price in the short term. This news may lead to a negative impact on the stock price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100